Diagnosis and Management of Insulin Resistant Polycystic Ovarian Syndrome: A Simplified Review

Insulin Resistant ◽

Abstract #782247: Polycystic Ovarian Syndrome: Variation in Diagnosis and Management

Endocrine Practice ◽

10.1016/s1530-891x(20)39422-2 ◽

2020 ◽

Vol 26 ◽

pp. 178

Author(s):

S.M. Ashrafuzzaman

Keyword(s):

Association of Diabetes Mellitus and Insulin Resistant in Polycystic Ovarian Syndrome (PCOS) Women in Kerala

IOSR Journal of Nursing and health Science ◽

10.9790/1959-03620507 ◽

2014 ◽

Vol 3 (6) ◽

pp. 05-07

Author(s):

Arghya Sur ◽

◽

Arindam Basu ◽

Hemontika Chakraborty

Keyword(s):

Diabetes Mellitus ◽

Insulin Resistant ◽

Type 2 Diabetes Mellitus - Genetics, Diagnosis and Management. Polycystic Ovarian Syndrome

Evidence-based Paediatric and Adolescent Diabetes ◽

10.1002/9780470692271.ch12 ◽

2008 ◽

pp. 175-196

Author(s):

John Porter ◽

Timothy G. Barrett

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Elevated diastolic blood pressure in insulin-resistant polycystic ovarian syndrome patients

Archives of Gynecology and Obstetrics ◽

10.1007/s00404-013-2953-2 ◽

2013 ◽

Vol 289 (1) ◽

pp. 119-122 ◽

Cited By ~ 3

Author(s):

Angélica Maria Holanda Pascoal da Silva ◽

Ana Carolina Rodrigues de Andrade ◽

Bruno Hállan Meneses Dias ◽

Maria Angelina da Silva Medeiros ◽

Vietla Satianarayana Rao ◽

...

Keyword(s):

Blood Pressure ◽

Diastolic Blood Pressure ◽

Insulin Resistant ◽

Polycystic ovarian syndrome: diagnosis and management of related infertility

Obstetrics Gynaecology & Reproductive Medicine ◽

10.1016/j.ogrm.2009.06.006 ◽

2009 ◽

Vol 19 (10) ◽

pp. 263-270 ◽

Cited By ~ 10

Author(s):

Saad A.K. Amer

Keyword(s):

Syndrome Diagnosis ◽

LOW DOSE SPIRONOLACTONE PROTECTS EXPERIMENTALLY-INDUCED POLYCYSTIC OVARIAN SYNDROME FROM INSULIN-RESISTANT METABOLIC DISTURBANCES

Journal of Hypertension ◽

10.1097/01.hjh.0000744648.83946.ef ◽

2021 ◽

Vol 39 (Supplement 1) ◽

pp. e28

Author(s):

Oluwaseun Adeyanju ◽

Timothy Falodun

Keyword(s):

Low Dose ◽

Metabolic Disturbances ◽

Insulin Resistant ◽

Ovarian Syndrome ◽

Experimentally Induced

Polycystic Ovarian Syndrome: Marked Differences Between Endocrinol-ogists and Gynaecologists in Diagnosis and Management

Yearbook of Endocrinology ◽

10.1016/s0084-3741(08)70442-6 ◽

2006 ◽

Vol 2006 ◽

pp. 383 ◽

Cited By ~ 1

Author(s):

A.W. Meikle

Keyword(s):

Polycystic Ovarian Syndrome in Adolescents: Keys to Diagnosis and Management

Pediatric Annals ◽

10.3928/19382359-20210622-01 ◽

2021 ◽

Vol 50 (7) ◽

Author(s):

Leah Khan

Keyword(s):

Investigation of the mechanism of action of duodenal mucosal resurfacing in insulin resistant women with polycystic ovarian syndrome. the DOMINO multicentre randomised controlled trial

Endocrine Abstracts ◽

10.1530/endoabs.70.aep799 ◽

2020 ◽

Author(s):

Georgios K. Dimitriadis ◽

Vasha Kaur ◽

Belen Pérez-Pevida ◽

Davinder Bansi ◽

Channa Jayasena ◽

...

Keyword(s):

Randomised Controlled Trial ◽

Mechanism Of Action ◽

Controlled Trial ◽

Insulin Resistant ◽

Randomised Controlled ◽

Very low dose spironolactone protects experimentally-induced polycystic ovarian syndrome from insulin-resistant metabolic disturbances by suppressing elevated circulating testosterone

Chemico-Biological Interactions ◽

10.1016/j.cbi.2019.108742 ◽

2019 ◽

Vol 310 ◽

pp. 108742

Author(s):

Oluwaseun A. Adeyanju ◽

Timothy O. Falodun ◽

Oyesanmi A. Fabunmi ◽

Lawrence A. Olatunji ◽

Ayodele O. Soladoye

Keyword(s):

Low Dose ◽

Metabolic Disturbances ◽

Insulin Resistant ◽

Ovarian Syndrome ◽

Experimentally Induced